HALO — HALOZYME THERAPEUTICS INC

Ownership history in ALGERT GLOBAL LLC  ·  18 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in HALOZYME THERAPEUTICS INC (HALO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.47% (2019 Q4)
Avg. % of fund
0.18%
First filed
2016 Q2
Last filed
2025 Q3
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 59,310 +10,640 +21.9% 0.07% $4.3M $73.34
2025 Q2 ADDED 48,670 +40,690 +509.9% 0.05% $2.5M $52.02
2025 Q1 REDUCED 7,980 -2,920 -26.8% 0.01% $509K $63.81
2024 Q4 REDUCED 10,900 -1,891 -14.8% 0.01% $521K $47.81
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HALO price (monthly, adj. close)

Other funds also holding HALO

As of 2025 Q4 — sorted by position size

Koa Wealth Management, LLC 4.3% SNYDER CAPITAL MANAGEMENT L P 3Y 7Y 3.01% Steamboat Capital Partners, LLC 3Y 7Y 2.66% South Street Advisors LLC 3Y 7Y 2.19% BERNZOTT CAPITAL ADVISORS 3Y 7Y 2.17% 2Xideas AG 3Y 1.98% Future Fund LLC 3Y 1.77% MIZUHO MARKETS AMERICAS LLC 3Y 1.65% Verity Asset Management, Inc. 3Y 7Y 1.53% RENAISSANCE GROUP LLC 3Y 7Y 1.3%
← Back to ALGERT GLOBAL LLC Holdings